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ABSTRACT
All group II introns known to date fold into six
functional domains. However, we recently identified
an intron in Bacillus cereus ATCC 10987, B.c.I4, that
splices 56nt downstream of the expected 30 splice
site in vivo (Tourasse et al. 2005, J. Bacteriol., 187,
5437–5451). In this study, we confirmed by ribonu-
clease protection assay that the 56-bp segment is
part of the intron RNA molecule, and computational
prediction suggests that it might form a stable
stem-loop structure downstream of domain VI. The
splicing of B.c.I4 was further investigated both
in vivo and in vitro. Lariat formation proceeded
primarily by branching at the ordinary bulged
adenosine in domain VI without affecting the fidelity
of splicing. In addition, the splicing efficiency of the
wild-type intron was better than that of a mutant
construct deleted of the 56-bp 30 extension. These
results indicate that the intron has apparently
adapted to the extra segment, possibly through
conformational adjustments. The extraordinary
group II intron B.c.I4 harboring an unprecedented
extra 30 segment constitutes a dramatic example of
the flexibility and adaptability of group II introns.
INTRODUCTION
Group II introns are a class of genetic retroelements that
are capable of self-splicing and mobility. They are able to
excise out of RNA transcripts and to ligate their ﬂanking
exons (self-splicing), and excised introns may subse-
quently insert (reverse splice) into identical intron-less
DNA sites (process called homing) or into novel genomic
locations (retrotransposition) [see (1–4) for reviews].
Group II introns are found in bacteria, archaea and the
organelles of fungi, plants and lower eukaryotes, and they
either interrupt genes or are inserted in intergenic regions
(5–7). These retroelements typically consist of a catalytic
RNA (ribozyme) containing an internal open reading
frame (ORF) encoding a multifunctional reverse-
transcriptase protein, although ORF-less introns do
exist, especially in eukaryotic organelles (5). While some
introns have been shown to self-splice in vitro in the
absence of protein, demonstrating that the splicing
reactions are intrinsically catalyzed by the intron RNA,
the intronic protein is required for both the splicing and
insertion events in vivo (1–4).
To date, known group II intron ribozymes normally
fold into conserved secondary structures consisting of six
domains that are linked by tertiary interactions, where
domain V contains a nucleotide triad that is the presumed
catalytic center (3,8,9). However, many degenerate introns
in eukaryotic organelles lack RNA substructures (4,10).
Diﬀerences in structure are used to divide the introns into
subclasses (9). Typically, the splicing occurs via a two-step
transesteriﬁcation mechanism that requires magnesium
(Mg
2þ) ions as cofactors (2–4). In the ﬁrst transesteriﬁca-
tion step, the 20 hydroxyl (20-OH) group of a bulged
adenosine (A) located in domain VI makes a nucleophilic
attack on the 50 exon–intron junction phosphodiester
bond, leading to cleavage of the 50 exon and formation of
a lariat (circle with tail) with 20–50 linkage. Due to
similarities in this splicing mechanism that involves the
formation of a branched lariat RNA molecule and shared
structural features group II introns are thought to be the
ancestors of the nuclear spliceosomal introns of eukar-
yotes (11,12). In the second transesteriﬁcation step, the
free 30-OH of the cleaved 50 exon attacks the 30 splice
junction, leading to exon ligation and release of the intron
lariat. However, an alternative hydrolytic pathway, in
which the ﬁrst splicing reaction is initiated by nucleophilic
attack by a water molecule leading to release of a linear
intron after transesteriﬁcation in the second step of
splicing has been shown to occur both in vitro and
in vivo (13–15). Group II introns have also been reported
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have been suggested (13,16).
Splice-site selection is determined by base-pairing
interactions between the intron and its ﬂanking exons
that help position the splice junctions in the active site of
the intron (Figure 1). At the 50 splice site two 5–6
nucleotide motifs, IBS1 and IBS2 (intron binding sites),
located just upstream of the intron insertion site base-pair
with the complementary EBS1 and EBS2 (exon binding
sites) in intron domain I. Two single base pair interactions
guide 30 splice-site selection, but they diﬀer between major
intron classes. For introns of class IIB, the ﬁrst nucleotide
of the 30 exon (IBS3) pairs with a nucleotide within
domain I [EBS3; (2–4,17)]. The second interaction
involves the last base of the intron (g0) and a base between
domain II and III (g) (Figure 1). The location of the 30
splice-site relative to the base of domain VI is also
important. For group IIB introns, the 30 splice site occurs
3 or 4nt past domain VI (10,18,19). It should be noted
that the correct positioning of the 30 splice site is actually
highly dependent on domain VI, which helps stabilize the
intron structure and the catalytic center (3).
We have recently reported a group IIB intron (B2-like
class), B.c.I4, on the pBc10987 plasmid of Bacillus cereus
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Figure 1. Predicted secondary structure of the B.c.I4 group II intron from B. cereus ATCC 10987. Exon nucleotides are in lowercase. Roman
numerals (I to VI) indicate the six typical functional RNA domains and their subdomains are designated by combinations of letters, numbers and
superscripts according to the nomenclature of (10). The extra 56-nt 30 segment harbored by B.c.I4 is boxed in grey. Sites corresponding to consensus
positions involved in tertiary interactions (8,9) are indicated by pairs of Greek letters or EBS/IBS (exon binding sites and intron binding sites).
Sites of tertiary base-pairing interactions are boxed or circled in red with arrows indicating the orientation of complementarity. Sites implicatedi n
other tertiary contacts are boxed or circled in blue. The IBS3–EBS3 and g–g0 base-pair interactions involved in 30 splice-site selection are indicated
by black dotted lines. The d0 nucleotide was set at the expected location (C:350) according to (17), however it is not complementary to the d site,
while nucleotide A:349 is. ORF, intron-encoded multifunctional open reading frame. Numbering of residues does not include the ORF. A–U, G–C
and G–U base pairs are linked by blue, red and green dots, respectively.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1613ATCC 10987 that splices in vivo 56nt downstream of
domain VI and the 30 splice site that would be expected
from secondary structure predictions (19). That is, an
extra 56-bp segment downstream of the intron was not
present in the ligated exons, as indicated by RT-PCR and
sequencing. B.c.I4 is inserted within a gene encoding a
hypothetical protein with a DNA primase domain
(BCEA0033þBCEA0036), and, interestingly, the unusual
splicing puts the ligated exons in-frame and would
produce a protein of exactly the same size as the intron-
less counterpart in other B. cereus group strains.
Furthermore, the observed 30 splice site would also give
the correct g–g0 and IBS3–EBS3 interactions, while non-
canonical pairings would form three or four bases
downstream of domain VI. In the present study, we
have examined the splicing of this extraordinary B.c.I4
intron in more detail using in vivo and in vitro experiments.
We show that the extra 56-bp 30 segment is an integral part
of the intron RNA molecule downstream of domain VI,
which represents a unique arrangement, and that 30 splice-
site selection can be more ﬂexible than ever seen before,
while branching is still maintained at the expected site.
MATERIALS AND METHODS
Secondary structure predictions
The secondary structure of the B.c.I4 intron RNA (ORF
removed) was computationally predicted by constrained
folding using the MFOLD 3.1 package (20) following the
consensus structure of group IIB introns from B2-like
class (9,19). That is, conserved and identiﬁable sequence
motifs corresponding to the consensus structure were
forced during the folding computation.
DNA andRNA isolation
Bacillus cereus ATCC 10987 was grown on Luria Bertani
(LB) agar plates at pH 7 and 308C. An overnight culture
(16h) was inoculated for 3.5h in 10ml LB, and then cells
were lysed with 10mg/ml lysozyme. DNA isolation was
performed using the Genomic DNA Midi kit (Qiagen) as
described by the supplier. Total RNA isolation was
conducted as in (19).
PCR and RT-PCR
PCR was performed with Dynazyme II using both the
forward and reverse primers at a concentration of 0.4mM,
each deoxynucleoside triphosphate at a concentration
of 0.8mM, and 1U of Dynazyme (Finnzymes). PCR was
primarily run with one denaturation step at 948C for
5min, followed by 30–38 cycles of 1min denaturation at
948C, 50s annealing at 588C and 50s extension at 728C,
followed by a ﬁnal extension step of 7min at 728C. For
RT-PCR, the synthesis of cDNA was initiated with the
reverse primers using Superscript III (Invitrogen) and 5mg
of total RNA or 0.1mg in vitro spliced RNA as a template
according to the supplier’s protocol. A negative control
was conducted without addition of reverse transcriptase.
A portion of the cDNA and negative control was then
ampliﬁed by PCR. A complete listing of all the primers
used in this study is given in Table 1.
PCR performed with 2.5U of Pfu Turbo DNA
polymerase (Stratagene), with same primers and dNTP
concentrations as earlier, was run with one denaturation
step at 958C for 2min, followed by 30 cycles of 30s
denaturation at 958C, 30s annealing at 588C and 1min/kb
extension at 728C, followed by a ﬁnal extension step of
10min at 728C.
Table 1. List of primers used in the study
Name Sequence Location
I4A_left TCGGATTTTTGCCGTTAGAG 50 exon
I4A_right ACCCCTTCTTATGTCGCAAA intron (50 end)
I4A_right_nested CAATCTTAATTCGTTGTGGGTGT intron (50 end)
I4B_left CCTGATGTGATCGGAGGTCT intron (30 end)
I4B_left_lariat GACATTAAACAGTCGATGGAACG intron (30 end)
I4B_left_BamHI
a CCCGGATCCCCTGATGTGATCGGAGGTCT intron (30 end)
I4B_right TGGTTTCGGAATGGAATCAT 30 exon
I4B_right_T7
a TAATACGACTCACTATAGGGAGAGCGGGATCCTGGTTTCGGAATGGAATCAT 30 exon
5p_left_BamHI
a CGGGATCCCGAAATTGTGTTGGAAGATGATAATACG 50 exon
3p_right_ClaI
a CCATCGATGGGGTCCAGATTTCACATGAACAG 30 exon
5p_right ATTCCATGAGCGATTGAGGT intron
3p_left AACCTTTAGATTGAGGAAACACAAA intron
d3ps_sense
b CCTTTGGGATGCGTCACAAATTATGAAATGAAGAAAGGACAAC 30 splice junction
d3ps_antisense
b GTTGTCCTTTCTTCATTTCATAATTTGTGACGCATCCCAAAGG 30 splice junction
d56_sense
b CATCAAAGATTTACCTATCGCA[ ]ATTTTATGAAATGAAGAAAGGAC 30 splice junction
d56_antisense
b GTCCTTTCTTCATTTCATAAAAT[ ]TGCGATAGGTAAATCTTTGATG 30 splice junction
Restore_sense
b CATCAAAGATTTACCTATCGCAATTGAAATGGGTAGGCGCTAC intron (30 end)
Restore_antisense
b GTAGCGCCTACCCATTTCAATTGCGATAGGTAAATCTTTGATG intron (30 end)
aNucleotides in boldface have been added to the primers in order to include restriction sites or promoters. The restriction sites for BamHI or ClaI are
underlined. The T7 promoter sequence is in italics.
bThe sense and antisense primers are complementary to each other and were used to generate the d3ps, d56, and ‘Restore’ mutant constructs using
Quikchange II (Stratagene). The mutated nucleotides are in bold. For the d56 mutant, the deletion point is indicated by brackets.
1614 Nucleic Acids Research, 2007, Vol. 35, No. 5Radioactive RT-PCR assay
The radioactive RT-PCR assay was mainly conducted
as described by Robart et al. (21). Primer I4B_right was
50-end-labeled with g
[32-P]ATP (3000Ci/mmol, 10mCi/ml)
using T4 kinase (New England Biolabs). Labeled primer
was puriﬁed with Nucleotide puriﬁcation kit (Qiagen).
Reverse transcription (cDNA synthesis) and PCR were
conducted as described earlier, except that PCR was
conducted with  5000cpm of labeled primer I4B_right
together with unlabeled counterpart (1pmol) and primer
I4A_left (4pmol) (Table 1). Ampliﬁcation products were
phenol–CIA (25:24:1 phenol:chloroform:isoamyl alcohol)
extracted, ethanol-precipitated with 0.3M NaOAc, pH 5.2
and digested with SnaBI (New England Biolabs) to ensure
homogeneous ends, and these samples were again
precipitated and eluted in formamide loading buﬀer
(Ambion). Samples were separated on 7M urea 6%
polyacrylamide gel after heating at 908C for 2min and
cooling on ice.
Cloning and site-directed mutagenesis
RT-PCR products, either taken directly or gel-puriﬁed
from 1X TAE gel (QIAquick gel extraction Kit, Qiagen),
were cloned into TA cloning vector (Invitrogen) and
subsequently sequenced.
Plasmid constructs for in vitro self-splicing experiments
were made by cloning a PCR product covering the entire
B.c.I4 intron and parts of the ﬂanking exons, ampliﬁed
with primers 5p_left_BamHI and 3p_right_ClaI (Table 1),
into the BamHI site of pBluescript II KSþ (Stratagene), in
orientation for T7 transcription. The intron-containing
inserts were then ampliﬁed by inverse PCR with outward
primers, 5p_right and 3p_left, using Pfu Turbo in order to
remove the ORF encoded in domain IV of B.c.I4, and
then ligated with T4 ligase (New England Biolabs), giving
a wild-type construct containing 96bp of the 50 exon,
884bp of intron and 151bp of the 30 exon.
Site-directed mutagenesis to generate point mutation
and deletion constructs was performed with Quikchange
II (Stratagene) according to the manufacturer’s instruc-
tions using two complementary oligonucleotides (of  40
bases) containing the desired mutation(s) (see Table 1 for
details). All constructs were veriﬁed by sequencing.
In vitro transcription
One microgram of plasmid construct was linearized by
XhoI for transcription reactions with 30U T7 RNA
polymerase (Ambion) according to the manufacturer’s
instructions. For radiolabeled transcripts, transcription
was performed using 20mCi
[a–32P] UTP (800Ci/mmol,
Amersham Pharmacia Biosciences), 0.1mM UTP and
0.5mM other NTPs. After DNAse treatment, transcripts
were gel-puriﬁed and resuspended in 10mM MOPS,
pH 7.5. Unlabeled transcripts were synthesized and
puriﬁed as for labeled transcripts, but with concentrations
of 0.5mM for each NTP and transcripts were gel-puriﬁed
after visualization with Fluor-coated TLC plates
(Ambion).
Ribonuclease protection assay
RNase T1/A protection assay (RPA) was performed using
the Ambion RPA III kit following the manufacturer’s
protocol. The RNA probe was synthesized from a PCR
product made using primers I4B_right_T7, containing a
T7 promoter and a 9-nt non-homologous sequence, and
I4B_left_BamHI (Table 1), creating a 422-nt long product
spanning over the 30 splice junction of intron B.c.I4.
The probe was synthesized by in vitro transcription as
described earlier, using 0.2mg of PCR product as template.
RPA reactions were performed using 10–25mg total RNA
and  60000cpm of gel-puriﬁed probe as described by the
manufacturer. After hybridization and digestion, probe
was separated on a denaturing 6% polyacrylamide/7M
urea gel. For imaging, gels were exposed and analyzed
using a Molecular Dynamics Storm 860 Phosphorimager.
Invitro self-splicing ofribozyme
In vitro generated transcripts were denatured and refolded
using a GenAmp 2700 PCR machine (Applied
Biosystems), by incubating the transcripts in 20mM
MOPS, pH 7.6 at 908C for 1min, 758C for 5min and
then cooling to the splicing temperature over 5min. Intron
transcripts were spliced with 50000cpm RNA or  0.1mg
unlabeled transcripts in 40mM MOPS, pH 7.6, 100mM
MgCl2 and 500mM (NH4)2SO4,N H 4Cl or KCl at the
temperatures indicated in the text. Reactions were
initiated by adding pre-warmed splicing buﬀer to the
transcript RNA giving a total reaction volume of 40ml. At
each time point 2ml were taken, quenched with loading
buﬀer (Ambion) and by placing samples on dry ice.
Samples were then heated to 958C and cooled on ice
before being separated on a 7M urea 4% polyacrylamide
gel. Gels were then vacuum dried, exposed and analyzed
using a Molecular Dynamics Storm 860 Phosphorimager.
For subsequent RT-PCR and sequencing of these
splicing products either unlabeled spliced transcripts,
puriﬁed with Nucleotide puriﬁcation kit (Qiagen), or
labelled spliced transcript species, excised from gels, were
used as templates.
For kinetic analysis the intensities of the radioactive
bands were quantiﬁed using the ImageQuant 5.0 software
and corrected by the number of uridines. The relative
fraction of unspliced precursor RNA was computed from
the intensities of the radioactive bands. Data were ﬁtted to
a biphasic exponential kinetic model [Equation (6) in (22)]
by the non-linear least squares method using the GNU
gretl 1.5.1 software (http://gretl.sourceforge.net/).
Reverse transcriptase primer extension
The I4B_right primer was 50-end-labeled with 40mCi of
g-[
32P]ATP and 15U of T4 polynucleotide kinase. Lariat,
lariat with 30 exon and precursor RNA were incubated
with 4mlo f5   ﬁrst-strand buﬀer (Invitrogen), 0.5mlo f
RNasOUT (40U/ml), 2pmol labeled primer at 858C for
10min and then transferred to 558C for 15min. The
reaction mixture was supplemented with 1ml of 0.1M
DTT, 40U of SuperScript III (Invitrogen), 1mlo f1 0m M
dNTPs. For primer extension reactions with precursor
Nucleic Acids Research, 2007, Vol. 35, No. 5 1615RNA 1ml of 4mM ddCTP was also added. The reaction
mixtures with total volume of 20ml were incubated at 558C
for 25min, and stopped by heating to 708C for 15min.
Reaction products were ethanol-precipitated in 0.3M
NaOAc, resuspended in Gel loading buﬀer II (Ambion),
heated to 958C for 2min and resolved in 7.5% poly-
acrylamide 7M urea gels and visualized using a Storm 860
scanner (Molecular Dynamics).
RESULTS
The extra 56-bpsegment downstream ofB.c.I4is partofthe
intronRNA molecule that splices in vivo
A ribonuclease protection assay was performed to
investigate whether the 56-bp sequence immediately
downstream of the B.c.I4 intron was part of the excised
intron in vivo as it was known to be absent from the
spliced exons (19). RNase digestion using a riboprobe
covering the intron-30 exon junction, including the
56-bp sequence, hybridized to total RNA from B. cereus
ATCC 10987 gave two bands: (1) a band migrating
at  400nt, which matches the size expected for the
unspliced (precursor) RNA (398nt) and (2) a band at
319nt that corresponds to the size of the spliced intron
with the extra 30 56-bp segment (Figure 2A). The assay
gave no indication of an excised intron without the extra
30 segment. To detect if there could be a small amount
of ligated exons that include the extra 56nt a sensitive
radioactive RT-PCR assay with total RNA was conducted
where spliced exons were ampliﬁed with 50-end-
labeled primer I4B_right and unlabeled primer I4A_left
(see Methods section). A single band at  147 bp was
obtained, corresponding to the size of the splice junction
sequenced previously with the same primers (19), but no
band containing the extra element was detected
(Figure 2B). We therefore conclude that the 56-bp
sequence 30 of B.c.I4 is part of the spliced intron RNA
in vivo.
The extra 30 segment of B.c.I4 ispredicted to fold into a
stablestem-loop structure
Computational secondary structure predictions suggest
that the 56-bp element at the 30 end of B.c.I4 would be
able to form a long stable stem-loop structure as
shown in Figure 3, although the folding of the ﬁrst part
of the element is unsure. If folding is conducted by
constraining the structure of domain VI to be as it would
be in a typical group IIB intron, then the ﬁrst 12nt of
the 56-nt segment would fold into a small stem–loop
element (Figure 3A), whereas they would partly extend the
base of the domain VI stem if no constraint is applied on
domain VI (Figure 3B). The overall secondary structure
of B.c.I4 (excluding the extra segment) displays all
the characteristics typical of group IIB introns belonging
to the B2-like class (9), in particular two stem–loop
structures inserted between subdomains I
(i) and I
(ii),
absence of subdomain IA, a 3-nt linker between domains
V and VI and a stretch of 4bp below the bulged A (A:899;
Figure 1 and ref. (19)). Furthermore, all sites involved in
tertiary interactions, with the exception of g0 and IBS3,
can be predicted at the expected locations and the
motifs match the consensus elements of group IIB2-like
introns (Figure 1). Therefore, the structure shown in
Figure 3B, which would imply important changes like
the disruption of the V–VI linker and an extension of
domain VI, might be less likely to form than the structure
shown in Figure 3A. Interestingly, no canonical g–g0
and IBS3–EBS3 base-pairings could form at the expected
A
B 1         2         3         4
1   2   3  4  5          6
100 nt
200 nt
245 nt
304 nt
400 nt
B.c.I4    3′ exon
B.c.I4    3′ exon
422 nt
398 nt
319 nt 
147 bp
217 bp
B.c.I4
Figure 2. RNase T1/A protection assay (A) and radioactive RT-PCR
(B) showing that the extra 56-nt element 30 of the B.c.I4 intron is part
of the intron RNA and not part of the exons. In A, lanes 1, 2 and 3
show positive controls based on mouse RNA, and lanes 4, 5 and 6
show the results based on B. cereus RNA. Lane 1: digested antisense
mouse b-actin RNA probe hybridized with mouse liver RNA; lane 2:
same probe as in lane 1, undigested; lane 3: same probe as in lane 1,
digested, without mouse liver RNA; lane 4: undigested B.c.I4-30exon
junction probe hybridized to B. cereus ATCC 10987 total RNA; lane 5:
same probe as in lane 4, digested, without RNA sample; lane 6: same
probe as in lane 4, digested, with RNA sample. A schematic of the
experiment illustrating the location of the probe and the expected
products is shown on the right. The black area represents the extra
56-nt element. In B, lanes 1, 2 and 3: RT-PCR conducted with exon-
speciﬁc primers I4B_right (radiolabeled) and I4A_left (Table 1) using
as template total RNA sample isolated from B. cereus ATCC
10987 at 3, 4 and 6h of growth, respectively. Lane 4: g
[32-P]ATP
50-end-labeled pBR322 DNA digested with MspI (New England
Biolabs), as marker.
1616 Nucleic Acids Research, 2007, Vol. 35, No. 5splice site three or four bases downstream of domain VI,
and both structure predictions suggest that the
potential g0 and IBS3 nucleotides (C:906 and C:907) at
this site would already be base-paired and unable to
interact with any other nucleotides. The stem–loop
structure(s) in the extra segment might enable the 30 end
of the intron to get in closer contact with the rest of the
intron core and bring the observed 30 splice site to a
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Figure 3. Predicted secondary structure of the 30 end of the B.c.I4 group II intron from B. cereus ATCC 10987. Domains V and VI and the extra
56-nt 30 segment are shown. A and B; two alternative structures for the wild-type intron. C; d56 mutant construct, in which the 56-nt element was
removed. D; ‘restore’ construct, in which the 30 splice site was restored at the expected location typical for group II introns, three bases downstream
of domain VI. The nucleotides at the expected 30 splice site in the wild-type intron, CCC, are colored in blue. These bases were mutated to AUU
(colored in red) in the ‘restore’ mutant. The observed 30 splice junction is indicated by an arrow. Exon residues are in lowercase. The three uridine
residues that might create potential 30 splice sites within the 56-nt 30 segment, which were not observed to be used, are colored in green. Nucleotides
boxed in blue were found to be linked to the intron’s 50 end in inverse RT-PCR experiments. The ordinary branchpoint bulged adenosine (A:899)
in domain VI is marked by an asterisk.
Nucleic Acids Research, 2007, Vol. 35, No. 5 1617location close to the site expected for typical group IIB
introns.
Invitro splicing analysis ofthe B.c.I4 intron
To study the role or impact of the extra 30 segment on the
splicing of the B.c.I4 intron, in vitro self-splicing experi-
ments were conducted using wild-type and mutant
constructs in the absence of intron-encoded protein. As
can be seen in Figure 4A, splicing of the B.c.I4 wild-type
(WT) intron done with 40mM MOPS (pH 7.5), 500mM
(NH4)2SO4 and 100mM MgCl2 at 458C followed by
separation of the splicing products on a polyacrylamide
gel revealed that the B.c.I4 intron could splice out as a true
ribozyme. The size of the ligated exon band observed on
the gel (Figure 4A) and RT-PCR with primers I4B_right
and 5p_left_BamHI (Table 1) and subsequent sequencing
conﬁrmed that the 56nt 30 of the intron were not part of
the ligated exons, verifying that in vitro splicing of B.c.I4
was the same as in vivo (Figure 4B). When the extra 30
segment was deleted from the intron (d56 construct), while
maintaining the last three nucleotides before the 30 splice
site (Figure 3C), the intron could still splice. As expected
the spliced exons were of the same sizes as for the wild
type, while the size of the lariat was smaller than the wild-
type lariat (Figure 4A). The smaller size of the d56 lariat
compared to wild type also conﬁrms that the extra element
was part of the lariat form of the wild-type intron that had
Figure 4. In vitro self-splicing (A)o fB.c.I4 wild-type and mutant constructs and subsequent RT-PCR (B). In A, lane M shows the marker, g
[32-P]ATP
50-end-labeled RNA Century-Plus Marker (Ambion). Splicing was performed in 40mM MOPS (pH 7.5), 500mM (NH4)2SO4, and 100mM MgCl2 at
458C. Samples were separated on a 7M urea 4% polyacrylamide gel. Schematic drawings are shown next to the bands corresponding to the diﬀerent
splicing products. The light grey box represents the extra 56-nt element. In B, RT-PCR with I4B_right and 5p_left_BamH1 primers (Table 1) using
in vitro splicing products as templates, conﬁrming the size of the ligated exons. Lane M, pBR322 DNA digested with MspI (New England Biolabs),
as marker. Samples were separated on a 1% agarose gel.
1618 Nucleic Acids Research, 2007, Vol. 35, No. 5spliced out. RT-PCR and sequencing conﬁrmed that the
ligated exons had the same sequence as in the wild-type
case and therefore the intron had spliced at the correct site
(Figure 4B). These results indicate that extra 30 element is
not essential for splicing in vitro.
We then investigated whether an intron construct
carrying the extra 30 sequence could splice at the location
expected for typical group IIB introns by restoring the
30 splice site three bases downstream of domain VI, i.e.
upstream of the extra 30 segment. In the ‘Restore’
construct, the nucleotides ACCC immediately after
domain VI were changed to AATT, thus providing a
potential 30 splice site that could interact with the g0
and EBS3 nucleotides of B.c.I4, without changing the
wild-type 30 splice-site sequence (Figure 3D). Remarkably,
the intron was able to splice at the restored site, as judged
by the spliced exons being  50nt longer in size than the
wild-type exons, but no product indicative of splicing at
the wild-type site 56 bp downstream of domain VI could
be observed (Figure 4A). RT-PCR and sequencing of
splicing products using primers located in the exons
(I4B_right and 5p_left_BamHI; Table 1) conﬁrmed that
ligated exons corresponded to splicing at the restored site
(Figure 4B). Interestingly, secondary structure predictions
using the restored mutant only produced one possible
folding in the 30 end of B.c.I4, whether or not constraints
are applied to domain VI. In that structure (Figure 3D),
domain VI would adopt the same conformation as in
typical group IIB introns, which might explain why
the restored site is preferred over the wild-type site.
In addition, the possible long linker that may form
between the restored site and the stem of the extra 56-bp
element may bring the wild-type site too far away from the
central core of the intron, thus preventing it from splicing
there.
Comparing the splicing of the wild-type B.c.I4 intron
with diﬀerent salts such as (NH4)2SO4,N H 4Cl and
KCl at the same concentration (500mM) by a 90-min
quantitative time-course analysis showed that the splicing
eﬃciency was best with (NH4)2SO4.S p l i c i n gw i t ht h i sl a t t e r
salt at various temperatures revealed that the rate of
splicing, as judged by the fraction of unreacted precursor
RNA, was highest between 47 and 508C (Figure 5A). While
previous results obtained with the d56 mutant construct
showed that the B.c.I4 intron could splice without the extra
56-bp segment (Figures 3C and 4), a time-course compar-
ison under the presumed optimal conditions revealed that,
overall, the d56 mutant intron was not more eﬃcient in
splicing than the wild-type B.c.I4 (Figure 5B).
30 splice-site selection
The use of an alternative 30 splice site by a bacterial group
II intron has been shown to occur both in vivo and in vitro
in B. anthracis, a close relative of B. cereus (21).
Interestingly, the 30 splice junction of B.c.I4, which is
delimited by two uridines (U) corresponding to the g0 and
IBS3 residues, is immediately followed by two more
uridines (Figure 3A and B). These latter nucleotides could
thus make two possible alternative splice sites where the
g–g0 and EBS3–IBS3 pairings with the g and EBS3
adenosines would be maintained. However, sequencing
of eight clones of RT-PCR products from in vivo ligated
exons did not reveal any use of either two possible
alternative splice sites by the B.c.I4 intron, and no
alternatively spliced exons could be observed in radio-
active RT-PCR assays performed on splicing products
from the wild-type RNA both in vivo and in vitro
(Figures 2B and 6). Nevertheless, this absence of detection
could be due to tiny amounts of alternative splicing.
To investigate further whether use of alternative splice
sites could be possible, the two ﬁrst U residues at the
intron-30 exon junction of the wild-type construct were
mutated to A nucleotides. Splicing of this mutant, d3ps
(Figure 4A), followed by RT-PCR (Figure 4B), cloning
and sequencing of ﬁve clones of ligated exon products
revealed that, in one case, the B.c.I4 intron could splice in
between the two uridines at the alternative 30 site located
at position þ2 downstream of the wild-type splice site.
Very surprising was the fact that the other four clones
showed sequences corresponding to splicing at the
mutated 30 splice site, i.e. in between the two adenosines.
In this case, no canonical IBS3–EBS3 pairing would form
as no U is present in the EBS3 internal loop, while a
uridine located in the linker between domain II and III
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Figure 5. Time-course analysis of in vitro self-splicing of B.c.I4 wild-
type (WT) and d56 mutant constructs. Splicing was performed in
buﬀers containing 100mM MgCl2 and 500mM (NH4)2SO4. The
relative fractions of unspliced precursor RNA were computed from
the intensities of the radioactive bands using a phosphorimager.
Reactions were repeated 3  for each construct, and are expressed as
averages with standard deviations. Data were ﬁtted to a biphasic
exponential kinetic model (Equation (6) in (22); rate constant estimates
are provided in supplementary Table 1).
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adenosine, the last nucleotide of the d3ps intron
(Figure 1). This suggests that either splicing occurs
without g–g0 and/or IBS3–EBS3 pairings or that non-
canonical interactions form. Quantiﬁcation of the 30 splice
site usage by the d3ps intron using radioactive RT-PCR
indicated that the mutated and alternative sites were used
in 55 and 45% of the splicing, respectively (Figure 6). It
should also be noted that there is a potential 30 splice site
inside the extra element, as three uridines can be found
(U:943–U:945; green bases in Figure 3), where no splicing
was observed.
Lariat andcircle formation
In typical group II introns domain VI contains a bulged
A, which is the branchpoint of the lariat, and has been
shown to be important for guiding 30 splice-site selection
usually 7–8nt downstream of the branchpoint (3). Since
intron B.c.I4 splices 56-nt downstream of domain VI, it
raises the question of whether the extra 30 element could
have an impact on the branchpoint selection.
B.c.I4 harbors a bulged A at the expected location in
domain VI (A:899). To investigate lariat formation in vivo
inverse nested RT-PCR experiments were performed using
outward-directed primers I4A_right/I4A_right_nested
and I4B_left (Table 1), located in the 50 and 30 end of
the intron, respectively, and total RNA isolated from
B. cereus ATCC 10987 (Figure 7A). Gel electrophoresis of
products revealed three diﬀerent bands, of which only the
smallest one was clearly visible each time the assay was
reproduced (Figure 7B). This band matched the size of a
lariat branching at the expected bulged A:899 in domain
VI and this was conﬁrmed by cloning and sequencing.
In the sequence, the bulged A residue was converted to T,
which is a characteristic error due to the reverse-
transcriptase which incorporates an A at the cDNA level
when it passes through a branched adenosine (15,23). This
result shows that B.c.I4 can branch at the typical site
within domain VI despite the presence of the extra 30
segment. The sequence of the largest inverse RT-PCR
product (Figure 7B, black arrow) corresponded to
molecules in which the ﬁrst and last intron nucleotides
were linked, potentially representing full-length intron
circles, while in the middle-size product (Figure 7B, grey
arrow) the ﬁrst intron nucleotide was linked to an internal
guanosine residue (G:921; Figure 3A and B) in the extra
30 element, i.e. the last 38 bases of the intron were missing.
In the radioactive RT-PCR experiment shown in
Figure 2B, no product corresponding to ligated exons
containing the last 38 bases of the intron could be
observed, indicating that the G:921 residue was not used
as an alternative 30 splice site. The middle-size product
could then represent an alternative lariat form or a partial
circle. Therefore, from the earlier results it appears that
B.c.I4 can generate a variety of heterogeneous products
in vivo. The band corresponding to lariat branching in the
expected bulged A:899 was by far the strongest
(Figure 7B, white arrow), indicating that this pathway
was the major one in vivo under the growth conditions
used.
When inverse RT-PCR was conducted on the products
of in vitro splicing with the WT construct using primers
I4A_right and I4B_left_lariat (Table 1), similar results
B
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WT      M
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5′ intron end
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5′ intron end
G:921
5′ intron end
5′ intron end
A:935
T:959
Figure 7. Inverse RT-PCR analysis for detection of B.c.I4 lariat and
other circular molecules. A; schematic drawing illustrating the inverse
PCR strategy and the location of primers. B; in vivo analysis; gel
electrophoresis of nested RT-PCR products obtained from total RNA
isolated from B. cereus ATCC 10987 cultures. C; in vitro analysis; gel
electrophoresis of RT-PCR products obtained from in vitro self-splicing
of B.c.I4 wild-type (WT). Sequencing chromatograms of selected
inverse RT-PCR products are shown to the right. The black, grey
and white arrows indicate full-length circles, molecules linked within
the extra 56-nt segment, and lariats branched in the bulged A:899,
respectively. In B and C, lane M shows the size marker, pBR322 DNA
digested with MspI (New England Biolabs); in B, lane NC shows a
negative control done without reverse-transcriptase. Primers I4A_right/
I4A_right_nested and I4B_left were used in B; I4A_right and
I4B_left_lariat were used in C (Table 1). Samples were separated on
a 3.5% NuSieve GTG agarose gel (Cambrex).
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100%         55%        WT
0%         45%    +2
GUCACAUUUU
GUCACA AAUU
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Figure 6. Radioactive RT-PCR assay for detecting the use of
alternative 30 splice sites. The assay was conducted with exon-speciﬁc
primers I4B_right (radiolabeled) and 5p_left_BamHI (Table 1) with
wild-type (WT) and d3ps mutant constructs spliced in vitro in 40mM
MOPS (pH 7.5), 500mM (NH4)2SO4 and 100mM MgCl2 at 458C.
While no alternative splicing was detected for the WT B.c.I4 intron, the
d3ps mutant could use a 30 splice site at position þ2 downstream of the
mutated wild-type site. Quantiﬁcation of the bands using a phosphor-
imager is shown, expressed as percentage of total radioactivity. The
intron-30 exon splice junction is shown on the right, with mutated
nucleotides boxed.
1620 Nucleic Acids Research, 2007, Vol. 35, No. 5were obtained (Figure 7C). The three mutant introns
(d3ps, d56 and restore) also gave rise to clones corre-
sponding to full circles (data not shown). To investigate
whether the molecules linked within the 56-bp 30 segment
could be lariats, inverse RT-PCR was run separately on
the fractions corresponding to ‘lariat’ and ‘lariatþ30 exon’
for the WT construct (top two bands in Figure 4A).
Although most of the clones (8 of 13 in ‘lariat’ and 12 of
17 in ‘lariatþ30 exon’) were lariats branched in A:899,
molecules in which the 50 intron nucleotide was linked to
G:921 were found in both fractions, and clones linked to a
variety of other sites present in either fraction (Figure 3A
and B and 7). Furthermore, a primer extension analysis
was conducted on the ‘lariatþ30 exon’ fraction (top band
in Figure 4A) using primer I4B_right located in the 30
exon. The strongest stop to reverse-transcription was by
far at position A:899 conﬁrming that this position is the
main branch site (Figure 8). There were no clear other
bands that could be indications of stops representing
minor ectopic branching events within the extra 56-bp
segment of B.c.I4, although this could also be due to a
very low frequency of these events, in agreement with the
observed frequencies in clones of inverse RT-PCR run on
the same fraction.
DISCUSSION
In this article, we have investigated the splicing of the
atypical group IIB (B2-like class) intron B.c.I4 of B. cereus
ATCC 10987 which splices, both in vivo and in vitro,5 6n t
downstream of the 30 site that would be predicted from
the classical 6-domain secondary structure of group II
introns (19). Here, we present data from three diﬀerent
types of experiments, i.e. ribonuclease protection assay,
radioactive RT-PCR and in vitro self-splicing, clearly
demonstrating that the extra 30 56-nt sequence is a part of
the intron that splices out and is not part of the ligated
exons (Figures 2 and 4). This is further supported
by the fact that this 56-nt sequence stretch is not present
in the sequence of the orthologous intron-less gene in
B. anthracis (ORF pXO1-70), B. cereus ATCC 43881 and
B. thuringiensis ATCC 33679 (19,24). This extraordinary
arrangement raises the question of how the intron
ribozyme can accommodate the extra element and be
functional. In this respect, it is remarkable that the
predicted secondary structure of B.c.I4 (apart from the
extra segment) conforms perfectly to the consensus
structure of group IIB2-like introns (Figure 1). All
motifs involved in tertiary interactions are also conserved
and no obvious feature deviating from the B2-like
consensus is apparent. This might suggest that B.c.I4 has
been able to accommodate the extra 30 segment without
major reorganization of the core structure. Use of the
downstream 30 splice site may be facilitated by the
formation of a long stable stem–loop structure in
the extra 56-nt element that could bring the observed 30
site closer to the (catalytic) core of the folded intron
(Figure 3). The predicted folding of this unusual sequence
is supported by the fact that no splicing was observed to
occur in the U:943–U:945 stretch, which could make a
potential 30 splice site with IBS3–EBS3 and g–g0 pairings,
as would be expected if these nucleotides are part of a
double-stranded stem (green bases in Figure 3A and B).
Furthermore, the nucleotides at the expected 30 splice site
are probably paired with other nucleotides either from the
56-nt element or the linker between domains V and VI
(blue bases in Figure 3A and B), therefore preventing
splicing at the location typical of group II introns.
Even though a more precise determination of the
secondary structure would require experimental probing,
it is likely that the structure downstream of domain VI is
important for the intron to be able to splice after the 56-nt
long 30 element. It would also be interesting to determine
whether this element is involved in tertiary interactions
with the other intron domains and/or the intron-encoded
protein.
When the downstream 30 segment is removed, as in the
d56 construct, the intron can still splice in vitro, indicating
that the extra sequence is not essential for B.c.I4 to splice
(Figure 4A). On the other hand, the splicing eﬃciency of
the d56 mutant in vitro in (NH4)2SO4 buﬀer is not better
A:935
A:899
G:921
G      A
lariat   |   3′  exon
Figure 8. Reverse transcriptase primer extension for detection of B.c.I4
lariat RNA. Primer extension was conducted on the ‘lariatþ30 exon’
fraction obtained from in vitro splicing of the wild-type B.c.I4 intron
(top band in Figure 4a) using primer I4B_right located in the 30 exon.
The same reaction was performed on precursor RNA using ddCTP and
ddTTP to produce the G and A ladder, respectively. A schematic of the
experiment is drawn to the right.
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of unspliced precursor during in vitro time-course analysis
in Figure 5), implying that the intron has adapted to
function with the extra 30 segment. Another sign of
adaptation is given by the fact that the expected
branchpoint (A:899) is still the most predominant both
in vivo and in vitro, and that B.c.I4 has a high ﬁdelity in
branch-site selection (Figures 7 and 8). It has been
extensively demonstrated that branch-site selection
occurs with a very high ﬁdelity in typical group II
introns (25). Thus, this observed ﬁdelity of B.c.I4 is
quite remarkable compared to other group II introns
in which the bulged A in domain VI is normally located
7–8nt upstream of the 30 splice site (3), as opposed to 60
bases.
Mutation of the 30 splice site (UU!AA) revealed
that the B.c.I4 intron could use an alternative site 2nt
downstream in vitro (Figure 6), indicating that B.c.I4
retains some ﬂexibility allowing the selection of an
alternative 30 site. This suggests that the 30 splice site
could come in close proximity to the catatylic center of
B.c.I4. On the other hand, the d3ps mutant also spliced
at the mutated site, where canonical IBS3–EBS3 and/or
g–g0 interactions are not expected to occur, implying
that there may be structural constraints limiting some-
what the ﬂexibility of the B.c.I4 intron. It could also be
that the IBS3–EBS3 and/or g–g0 interactions are not
critical for 30 splice-site selection by B.c.I4, as these
interactions support correct 30 splice-site choice only
when the 30 splice site is located near the active center
of the intron (3). Alternative splicing of a bacterial
group II intron has been reported in B. anthracis,a
close relative of B. cereus (21). However, no evidence
for such an event could be obtained for the wild-type
B.c.I4 intron both in vivo and in vitro under the
conditions tested (Figures 2B and 6).
Although the B.c.I4 intron follows a two-step transes-
teriﬁcation splicing reaction using the bulged A in domain
VI, results from inverse RT-PCR could indicate that
minor products may be formed, as suggested by the
detection of molecules in which the 50 end of the intron
was linked to a nucleotide inside the extra 56-nt 30 element
or linked to the 30 end of the intron. These products were
obtained both in vivo and in vitro, thus indicating that
their formation is not due to the action of the intron-
encoded protein or host factors (e.g. RNA ligase).
Molecules in which the 50 and 30 intron ends are joined
are suggestive of fully circularized intron RNAs.
Alternatively, they could be the result of reverse splicing
into precursor RNA (26,27) or template switch by the
reverse-transcriptase during cDNA synthesis (28,29) lead-
ing to head-to-tail intron tandems. Fully circular group II
intron RNAs have been reported for a number of elements
from organelles of fungi and plants (13,15,16) and recently
in the bacterium Sinorhizobium meliloti (30,31),
either in vitro or in vivo, and some of these introns exhibit
obvious unusual features in their 30 ends. If circle
formation does occur, it seems to be a minor pathway
for the wild-type B.c.I4 intron under the in vivo
and in vitro conditions tested in this study. With respect
to the molecules that are linked within the extra 56-nt 30
segment, whether they represent ectopic lariats or
small circles is unclear. Circular products lacking
30 terminal nucleotides of the intron have been observed
in vivo in plant mitochondria (13) and chloroplasts (15). In
the case of B.c.I4, this type of molecules does not seem to
be a result of splicing or hydrolysis at these ligation points,
as the corresponding exonic products were not observed
(Figures 2B, 4A and 6). Another alternative is that
these molecules are lariats branched within the extra
30 segment. As shown by Chu et al. (25), intron mutants
exhibiting ectopic branching still give correct joined exon
products. Recently, ectopic branching was suggested
to explain diﬀerent splicing products obtained when
mutating the bulged A in the Lactococcus lactis LtrB
intron (32). Similar events in B.c.I4 could be due to
structural interference by the 56-nt 30 element, e.g. when
domain VI docks into domain I (33), in a minority of
cases. However primer extension assay did not reveal
evidence for ectopic branchpoints and we cannot exclude
the possibility that these products may be the result of RT-
PCR artifacts or structural eﬀects.
The intron characterized in this study, B.c.I4,
carrying a 30 extra segment gives a dramatic new
example of the ﬂexibility and adaptability of group II
introns. B.c.I4 has been able to accommodate an
additional 56nt and still remains functional for splicing
with high ﬁdelity of branch-site and splice-site selection.
This is probably due to some favorable conformational
adjustments. The versatility of group II introns can also
be seen in the splicing ability of elements lacking the
branching A or exhibiting various unusual features in
domains V and/or VI, which are still able to splice
via alternative pathways like hydrolytic splicing or
formation of various circular forms (13,15). This
adaptability may have contributed to the survival and
maintenance of group II introns in genomes where they
have to cope with varying physiological conditions
aﬀecting splicing.
Finally, a puzzling question relates to the origin of this
extra 56-bp element. How did B.c.I4 acquire it and from
where? Since the 30 element is absent from the intron-less
gene orthologous to B.c.I4’s host gene in other B. cereus
group strains, this element probably originated from
another genomic context. A PCR screening of a set of
25 B. cereus group strains from our collection using
primers speciﬁc to B.c.I4 and the 30 exon (BCEA0036)
covering the intron-30 exon junction indicated that similar
B.c.I4 copies including the 56-nt segment are present in
homologous host genes in three other strains from the
group (results not shown). Therefore, B.c.I4 and its
30 extra segment are not unique to B. cereus ATCC
10987. However, the latter segment does not show
similarity to any other sequence in the public databases
(both at the nucleotide and amino-acid levels), thus
providing no clues about its origin. It would also be
interesting to determine whether B.c.I4 is capable of
mobility and whether the extra 56-nt segment has any
impact on the ability to reverse splice into DNA sites.
Indeed, the B.c.I4-encoded protein contains the endonu-
clease motif involved in mobility (19).
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